Full Text:   <2939>

Summary:  <2311>

CLC number: R736.1

On-line Access: 2024-08-27

Received: 2023-10-17

Revision Accepted: 2024-05-08

Crosschecked: 2014-11-14

Cited: 0

Clicked: 6049

Citations:  Bibtex RefMan EndNote GB/T7714

 ORCID:

Wei-dong ZHANG

http://orcid.org/0000-0002-6574-1542

Li CHEN

http://orcid.org/0000-0001-9699-6006

-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE B 2014 Vol.15 No.12 P.1081-1087

http://doi.org/10.1631/jzus.B1400124


Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literature*


Author(s):  Wei-dong Zhang1, Da-ren Liu1, Cheng-cheng Feng2, Chuan-biao Zhou1, Chen-ni Zhan1, Ri-sheng Que1, Li Chen1

Affiliation(s):  1. Department of Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China; more

Corresponding email(s):   chenli_hz@yahoo.com

Key Words:  Thyroid carcinoma, Bone metastasis, Management


Wei-dong Zhang, Da-ren Liu, Cheng-cheng Feng, Chuan-biao Zhou, Chen-ni Zhan, Ri-sheng Que, Li Chen. Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literature[J]. Journal of Zhejiang University Science B, 2014, 15(12): 1081-1087.

@article{title="Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literature",
author="Wei-dong Zhang, Da-ren Liu, Cheng-cheng Feng, Chuan-biao Zhou, Chen-ni Zhan, Ri-sheng Que, Li Chen",
journal="Journal of Zhejiang University Science B",
volume="15",
number="12",
pages="1081-1087",
year="2014",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1400124"
}

%0 Journal Article
%T Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literature
%A Wei-dong Zhang
%A Da-ren Liu
%A Cheng-cheng Feng
%A Chuan-biao Zhou
%A Chen-ni Zhan
%A Ri-sheng Que
%A Li Chen
%J Journal of Zhejiang University SCIENCE B
%V 15
%N 12
%P 1081-1087
%@ 1673-1581
%D 2014
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1400124

TY - JOUR
T1 - Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literature
A1 - Wei-dong Zhang
A1 - Da-ren Liu
A1 - Cheng-cheng Feng
A1 - Chuan-biao Zhou
A1 - Chen-ni Zhan
A1 - Ri-sheng Que
A1 - Li Chen
J0 - Journal of Zhejiang University Science B
VL - 15
IS - 12
SP - 1081
EP - 1087
%@ 1673-1581
Y1 - 2014
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1400124


Abstract: 
Differentiated thyroid carcinoma (DTC) is a common malignancy. The general treatments are thyroidectomy of the affected lobe along with lymphadenectomy. However, bone metastasis is rare in DTC compared with other malignancies and the management of metastasis foci is still controversial. Here we present a case of follicular thyroid carcinoma with the 6th cervical vertebra body metastasis successfully treated by total thyroidectomy, cervical corpectomy, and internal fixation, followed by hormone replacement therapy and radioiodine therapy. Eleven additional patients diagnosed as thyroid carcinoma with bone metastasis collected from Chinese literature between January 1996 and December 2013 were also reviewed. The mean age of the 12 patients at presentation was (53.9±9.2) years (rang, 42–72 years) and the male to female ratio was 1:2. Nine cases received total/near-total thyroidectomy or lobectomy while the other three patients refused for personal reasons. The interventions for bone metastasis were one-stage operation (9/12), I131 adjuvant therapy (3/12), chemotherapy (1/12), and no intervention (1/12). During the follow-up, two patients died of metastatic carcinoma recurrence, one died of multiple organ metastasis, and one with an unknown reason. We conclude that the management of thyroid carcinoma with bone metastasis needs multidisciplinary cooperation. Surgical resection is still the first choice for cure, while the combined one-stage operation on the primary and metastatic sites followed by hormone replacement therapy and radioiodine therapy is an applicable treatment.

甲状腺癌骨转移的诊疗措施的个例报道及其文献回顾

探究甲状腺癌骨转移的规范诊疗措施,为提高甲状腺癌骨转移的生存期提供指导。 本例病人通过普外科、骨科联合手术,内分泌激素替代治疗,I治疗等多学科联合治疗,取得较好的疗效,对探究甲状腺癌骨转移的规范化诊疗措施有重要的指导意义。 本文分析本科室一例甲状腺癌骨转移病人,同时搜集了1996年至2013年中文文献报道的甲状腺癌骨转移患者11例,通过统计其病理类型、手术方式、转移部位、随访资料等,讨论其规范化治疗方式。 彻底的术前检查对发现甲状腺癌骨转移至关重要。甲状腺癌骨转移需要多学科协同治疗,手术治疗仍为首选,联合手术的激素替代治疗、I治疗、二膦酸盐治疗是较好的选择。放疗的作用仍需大样本数据的评估。
甲状腺癌;骨转移;诊疗措施

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

References

[1] Ao, Y.Z., Dong, S., 1998. Bone metastasis revealed thyroid carcinoma: 2 cases. Chin J Clin Oncol, (in Chinese),25(6):53

[2] Baudin, E., Schlumberger, M., 2007. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol, 8(2):148-156. 


[3] Bernier, M.O., Leenhardt, L., Hoang, C., 2001. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab, 86(4):1568-1573. 


[4] Chen, Z.H., Huang, T.Q., Li, W., 2013. Metastatic follicular thyroid carcinoma to the mandible: a case report and literature review. J Dent Prev Treat, (in Chinese),21(10):535-539. 

[5] Chen, Z.Q., Wang, X., Xing, J.L., 1996. Lumbar vertebral body revealed thyroid carcinoma: a case report. Orthop J China, (in Chinese),4(3):234

[6] Delank, K.S., Wendtner, C., Eich, H.T., 2011. The treatment of spinal metastases. Dtsch Arztebl Int, (in German),108(5):71-79. 


[7] Hovens, G.C., Stokkel, M.P., Kievit, J., 2007. Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab, 92(7):2610-2615. 


[8] Hu, S., Pei, Y.E., Zhu, Y.J., 2003. Thyroid carcinoma with skull metastasis: 2 cases. Chin J Clin Neurosurg, (in Chinese),8(2):47

[9] Jin, J., Phitayakorn, R., Wilhelm, S.M., 2013. Advances in management of thyroid cancer. Curr Probl Surg, 50(6):241-289. 


[10] Klain, M., Ricard, M., Leboulleux, S., 2002. Radioiodine therapy for papillary and follicular thyroid carcinoma. Eur J Nucl Med Mol Imaging, 29(S2):S479-S485. 


[11] Muresan, M.M., Olivier, P., Leclere, J., 2008. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer, 15(1):37-49. 


[12] Orita, Y., Sugitani, I., Toda, K., 2011. Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. Thyroid, 21(1):31-35. 


[13] Pasupula, A.P., Dorankula, S.P., Thokala, M.R., 2012. Metastatic follicular thyroid carcinoma to the mandible. Indian J Dent Res, 23(6):843


[14] Petrich, T., Widjaja, A., Musholt, T.J., 2001. Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age. Eur J Nucl Med, 28(2):203-208. 


[15] Proye, C.A., Dromer, D.H., Carnaille, B.M., 1992. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?. World J Surg, 16(4):640-645. 

[16] Qiu, Z.L., Song, H.J., Xu, Y.H., 2011. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab, 96(10):3078-3086. 


[17] Ramadan, S., Ugas, M.A., Berwick, R.J., 2012. Spinal metastasis in thyroid cancer. Head Neck Oncol, 4(1):39


[18] Santini, D., Fratto, M.E., Vincenzi, B., 2006. Zoledronic acid in the management of metastatic bone disease. Expert Opin Biol Ther, 6(12):1333-1348. 


[19] Schlumberger, M., Challeton, C., de Vathaire, F., 1996. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med, 37(4):598-605. 


[20] Sherma, S.I., 2003. Thyroid carcinoma. Lancet, 361(9356):501-511. 


[21] Si, C., Guan, M., 2007. Differentiated thyroid carcinoma with bone metastasis: analysis of 5 cases. Mod J Integr Tradit Chin West Medline, (in Chinese),16(22):3196-3197. 

[22] Sosa, J.A., 2013. Is routine prophylactic central neck dissection indicated for low-risk papillary thyroid cancer: can we determine cost-effectiveness if we are unsure about its effectiveness and safety?. Surgery, 154(6):1146-1147. 


[23] Sugino, K., Kameyama, K., Nagahama, M., 2014. Follicular thyroid carcinoma with distant metastasis: outcome and prognostic factor. Endocr J, 61(3):273-279. 


[24] Tokuhashi, Y., Matsuzaki, H., Oda, H., 2005. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine, 30(19):2186-2191. 


[25] Tomita, K., Kawahara, N., Kobayashi, T., 2001. Surgical strategy for spinal metastases. Spine, 26(3):298-306. 


[26] Venkat, R., Guerrero, M.A., 2013. Recent advances in the surgical treatment of differentiated thyroid cancer: a comprehensive review. Sci World J, 2013:425136


[27] Wu, K., Hou, S.M., Huang, T.S., 2008. Thyroid carcinoma with bone metastases: a prognostic factor study. Clin Med Oncol, 2:129-134. 


[28] Zaydfudim, V., Feurer, I.D., Griffin, M.R., 2008. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery, 144(6):1070-1078. 


[29] Zhang, D., Yin, H., Wu, Z., 2013. Surgery and survival outcomes of 22 patients with epidural spinal cord compression caused by thyroid tumor spinal metastases. Eur Spine J, 22(3):569-576. 



Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE